Genomics

Dataset Information

0

CRISPR screens are feasible in TP53 wild-type cells

ABSTRACT: CRISPR-Cas9 genome-wide screens were performed in retinal pigment epithelial cells (RPE1) with either wild-type TP53 gene, or a TP53-null background. Results show wild-type TP53 has minimal impact on the efficiency of CRISPR dropout screens.

ORGANISM(S): Homo sapiens

PROVIDER: GSE128210 | GEO | 2019/04/30

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics CRISPR screens are feasible in TP53 wild-type cells
| PRJNA526806 | ENA
Unknown Pooled CRISPR screens in human intestinal organoids [CRISPR screens]
2020-02-26 | GSE145184 | GEO
Unknown Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness
2019-08-06 | GSE132340 | GEO
Proteomics nascent proteome analysis of HCT116 TP53 wild type and TP53 knockout cells treated with Neocarcinostatin (NCS) for 6h
2022-04-27 | PXD029512 | Pride
Genomics Pooled CRISPR screens in human intestinal organoids [CRISPR screens]
| PRJNA608420 | ENA
Unknown Pooled CRISPR screens in human intestinal organoids [RNA-seq]
2020-02-26 | GSE145308 | GEO
Unknown Pooled CRISPR screens in human intestinal organoids [CUT&RUN]
2020-02-26 | GSE145183 | GEO
Unknown Pooled CRISPR screens in human intestinal organoids [ATAC-seq]
2020-02-26 | GSE145182 | GEO
Unknown TP53 wild type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
2021-11-20 | GSE189152 | GEO
Unknown CRISPR-based epigenome editing screens identify transcriptional and epigenetic regulators of human CD8 T cell function [Sorting-based CRISPR screens]
2023-08-31 | GSE241933 | GEO